Taisho Pharmaceutical Holdings Co Ltd (TAISF)
OTHER OTC:TAISF
US Market
Holding TAISF?
Track your performance easily

Taisho Pharmaceutical Holdings Co (TAISF) Cash flow

4 Followers

Taisho Pharmaceutical Holdings Co Cash Flow

TAISF's free cash flow for Q3 2022 was $―. For the 2022 fiscal year, TAISF's free cash flow was decreased by $-13.54B and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 22Mar 21Mar 20Mar 19Mar 18
Operating Cash Flow
-$ 28.51B$ 42.03B$ 41.99B$ 19.22B$ 39.85B
Investing Cash Flow
-$ -7.06B$ -1.96B$ -107.08B$ 66.04B$ -19.91B
Financing Cash Flow
-$ -10.06B$ -11.35B$ -11.70B$ -15.47B$ -9.87B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-$ 227.51B$ 215.35B$ 186.94B$ 263.55B$ 194.36B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
-$ 4.40B$ 4.85B$ 270.00M$ 211.00M$ 378.00M
Repayment Of Debt
-$ -4.30B$ -5.04B$ -1.53B$ -187.00M$ -365.00M
Free Cash Flow
-$ 14.12B$ 27.65B$ 32.87B$ 14.31B$ 34.84B
Domestic Sales
------
Foreign Sales
------
Currency in USD

Taisho Pharmaceutical Holdings Co Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis